4//SEC Filing
Bellon Steven F. 4
Accession 0001562180-23-000726
CIK 0001822462other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:03 PM ET
Size
5.5 KB
Accession
0001562180-23-000726
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-26+100,000→ 100,000 totalExercise: $8.38Exp: 2033-01-25→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001831749
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 5:03 PM ET
- Size
- 5.5 KB